DK0802796T3 - Kyllingeanæmimiddel-broiler vaccine - Google Patents

Kyllingeanæmimiddel-broiler vaccine

Info

Publication number
DK0802796T3
DK0802796T3 DK96900947T DK96900947T DK0802796T3 DK 0802796 T3 DK0802796 T3 DK 0802796T3 DK 96900947 T DK96900947 T DK 96900947T DK 96900947 T DK96900947 T DK 96900947T DK 0802796 T3 DK0802796 T3 DK 0802796T3
Authority
DK
Denmark
Prior art keywords
vaccine
kyllingeanæmimiddel
broiler
production losses
broilers
Prior art date
Application number
DK96900947T
Other languages
Danish (da)
Inventor
Carla Christina Schrier
Dijk Pieter Matthijs Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0802796T3 publication Critical patent/DK0802796T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention for the first time discloses a health problem in broilers at about 3-5 weeks, resulting in significant production losses, and demonstrates that these production losses can be prevented by a live attenuated CAA vaccine for mucosal administration.
DK96900947T 1995-01-06 1996-01-04 Kyllingeanæmimiddel-broiler vaccine DK0802796T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200018 1995-01-06
PCT/EP1996/000122 WO1996020727A1 (en) 1995-01-06 1996-01-04 Chicken anaemia agent broiler vaccine

Publications (1)

Publication Number Publication Date
DK0802796T3 true DK0802796T3 (en) 2002-01-21

Family

ID=8219942

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96900947T DK0802796T3 (en) 1995-01-06 1996-01-04 Kyllingeanæmimiddel-broiler vaccine

Country Status (12)

Country Link
US (1) US6270770B1 (en)
EP (1) EP0802796B1 (en)
JP (1) JP4050312B2 (en)
AT (1) ATE206310T1 (en)
AU (1) AU4486096A (en)
BR (1) BR9606725A (en)
DE (1) DE69615656T2 (en)
DK (1) DK0802796T3 (en)
ES (1) ES2167536T3 (en)
MX (1) MX9705068A (en)
PT (1) PT802796E (en)
WO (1) WO1996020727A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
BR112013009012A2 (en) 2010-10-13 2016-07-12 Celanese Int Corp process for the recovery of halogen promoters and disruption of permanganate reducing compounds
CN106248932A (en) * 2016-08-18 2016-12-21 山东新四维农业科技有限公司 A kind of discrimination method for the medium-sized young layer of high-quality
CN115058522B (en) * 2022-07-21 2023-06-13 江苏省家禽科学研究所 Molecular marker for identifying broiler breeds containing white roc blood margin and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
US5686077A (en) * 1991-09-20 1997-11-11 Akzo Nobel N.V. Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.

Also Published As

Publication number Publication date
DE69615656T2 (en) 2002-08-01
EP0802796B1 (en) 2001-10-04
ES2167536T3 (en) 2002-05-16
WO1996020727A1 (en) 1996-07-11
BR9606725A (en) 1998-01-13
US6270770B1 (en) 2001-08-07
AU4486096A (en) 1996-07-24
PT802796E (en) 2002-02-28
MX9705068A (en) 1997-10-31
JP4050312B2 (en) 2008-02-20
EP0802796A1 (en) 1997-10-29
JPH10511945A (en) 1998-11-17
DE69615656D1 (en) 2001-11-08
ATE206310T1 (en) 2001-10-15

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
MX9204625A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A MAMMAL SPECIES, WHICH SUFFERS FROM CONGESTIVE HEART DEFICIENCY.
NO20053106D0 (en) Oral, extended-release analgesic dosage form.
DK0661973T3 (en) Procedure for Preventing NMDA Receptor Complex Mediated Neuronal Injury
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
BG100960A (en) DOSAGE FORMS WITH CONTROLLED RELEASE OF ASITROMYCIN
DE69131014D1 (en) RECOMBINANT AVIRULENT SALMONELLA ANTI-FERTILITY VACCINE
FI912636L (en) ENERGIPRODUKTIONSANORDNING, SPECIELLET VID FARTYG MED PROPELLERDRIVEN DRIFTSANORDNING, FOERSEDD MED SOLGENERATOR.
GB0109146D0 (en) Treatment of type 2 diabetes
FI971732L (en) Vaccine and antitoxin to treat and prevent disease caused by C. difficile
ITBO910182A1 (en) EQUIPMENT FOR HEMODIAFILTRATION TREATMENTS.
EA200400455A1 (en) METHOD FOR PREPARING A QUICKLY SOLUBLE DOSAGE FORM
DK0802796T3 (en) Kyllingeanæmimiddel-broiler vaccine
ES2170143T3 (en) COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM.
BG101401A (en) ORAL COMPOSITIONS WITH OVERALL RELEASE OF CISAPRID
DE59204452D1 (en) Root implant.
DE69107150D1 (en) 1,1,1-trishdroxyphenylethane acrylates.
KR930702004A (en) Direct compression method for preparing tablets containing cephalosporan acid derivatives
FI911656A0 (en) DRIFTENHET, SPECIELLT FOER EN POLERMASKIN VID EN PAPPERSMASKIN.
AU2003273884A1 (en) Chicken astrovirus type 2
DE69930952D1 (en) TAXED RELEASE OF ANTIDEPRESSIVA
RU98121717A (en) METHOD FOR TREATING ALLERGIC DISEASES
ITPS910019A0 (en) -INSERT FOR ENDOSSEAL IMPLANTOLOGY IN DENTISTRY.
FR2663219B1 (en) ARMCHAIR FOR MEDICAL TREATMENTS.
NL300165I1 (en) Babesia vaccine.